ACRONIS owner Contact Information online
from BASF SE
ACRONIS
US serial number:85080077
Application filling date:Jul. 08, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 10, 2012
Publication date:Mar. 15, 2011
Abandoned date:Dec. 10, 2012
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Chemical preparations for use in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds
International Class(es): 001- Primary Class
U.S Class(es): 001,005,006,010,026,046
Class Status: ACTIVE
Basis: 1(b)
For
Services:Chemical preparations for use in agriculture
horticulture and forestry
namely
chemical preparations for the treatment of seeds
Current owner owner name:BASF SE
Current owner owner address:Carl-Bosch-Strasse 38
Ludwigshafen am Rhein
GERMANY
Current owner legal entity type:societas europae (se)
Current owner state or country:GERMANY
Attorney name:Joyce M. Ferraro
Attorney email:jferraro@frosszelnick.com
Attorney docket number:BASF 1004656
Attorney email authorized:No
Correspondent name address:JOYCE M. FERRARO
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017-1822
Correspondent phone:(212) 813-5900
Correspondent email:ferraro-docket@fzlz.com
Correspondent fax:(212) 813-5901
Correspondent email authorized:Yes
Trademark staff tm attorney:CORWIN, KEVIN SCOTT
Trademark staff law office assigned ACRONIS:LAW OFFICE 112
Latest trademarks
Popular owners
Glaxo Group Limited (174) JOHNSON & JOHNSON (136) Novartis AG (134) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (43) Pfizer Inc. (41) Wyeth LLC (41) Bristol-Myers Squibb Company (35) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (29) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 15, 2011 Mar. 08, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Apr. 05, 2011 Sep. 28, 2010Similar brands
